ESMO – European Society for Medical Oncology shared on LinkedIn:
“ESMO Preceptorship on NSCLC and SCLC, 9-10 December 2024 in Singapore:
Multidisciplinary management, standards of care, therapeutic targets and future perspectives. Learning objectives include:
- Best clinical practice in the management of NSCLC in early, locally advanced and metastatic stages.
- Management of patients with actionable driver alterations and novel targeted agents for advanced NSCLC.
- The role of immune checkpoint blockade for Lung Cancer and to learn about novel immunotherapies.
- The systemic treatment of SCLC.
In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to selected applicants as a contribution towards their travel costs.
Application deadline: 10 September 2024.
Apply now.”
Source: ESMO/LinkedIn